NCT06883448 - Implementation of Home Monitoring in Patients with Pulmonary Fibrosis | Biotech Hunter

Enrollment

220

Participants

Timeline

Start Date

October 2, 2024

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2026

Conditions

Pulmonary FibrosisInterstitial Lung Disease (ILD)

Interventions

COMBINATION_PRODUCT

Home monitoring care

Patients in the home monitoring group will receive a home spirometer, pulse oximetry meter, and access to a smartphone or tablet app, where they can perform home based measurements weekly and complete PROMs. Furthermore, this app includes disease specific information and allows for direct communication with the hospital via eConsultation. In the home monitoring group, half of the outpatient clinic visits will alternately be replaced by remote visits via video consultation.

Trial Locations (11)

Unknown

RECRUITING

Department of Pulmonology, Onze Lieve Vrouwe Gasthuis, Amsterdam

RECRUITING

Department of Pulmonary Diseases, Rijnstate Hospital, Arnhem

RECRUITING

Department of Respiratory Medicine, Amphia Hospital, Breda

RECRUITING

Department of Respiratory Medicine, Catharina Hospital, Eindhoven

ACTIVE_NOT_RECRUITING

Department of Pulmonary Medicine, Zuyderland Medical Centre, Heerlen

RECRUITING

Department of Pulmonology, Medical Center Leeuwarden, Leeuwarden

RECRUITING

Department of Pulmonology, Leiden University Medical Center, Leiden

ACTIVE_NOT_RECRUITING

Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein

RECRUITING

Department of Respiratory Medicine, Center of Excellence for Interstitial Lung Disease, Erasmus University Medical Center, Rotterdam

RECRUITING

Department of Pulmonology, Haaglanden Medisch Centrum, The Hague

RECRUITING

Division of Heart and Lungs, University Medical Center Utrecht and Utrecht University, Utrecht